Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Bone Morphogenetic Protein Receptors, Type II | 9 | 2022 | 68 | 3.800 |
Why?
|
Alstrom Syndrome | 7 | 2023 | 11 | 3.560 |
Why?
|
Hypertension, Pulmonary | 15 | 2023 | 1534 | 3.350 |
Why?
|
Bardet-Biedl Syndrome | 7 | 2023 | 42 | 3.310 |
Why?
|
Activin Receptors, Type II | 4 | 2018 | 127 | 1.690 |
Why?
|
Group II Chaperonins | 2 | 2019 | 7 | 1.250 |
Why?
|
Exons | 7 | 2023 | 2439 | 1.220 |
Why?
|
Mutation | 26 | 2022 | 29786 | 1.120 |
Why?
|
Spain | 11 | 2021 | 465 | 1.070 |
Why?
|
Genetic Association Studies | 9 | 2023 | 2703 | 1.020 |
Why?
|
Hypertension, Portal | 3 | 2017 | 220 | 1.010 |
Why?
|
Microtubule-Associated Proteins | 3 | 2019 | 1085 | 0.930 |
Why?
|
Genetic Markers | 6 | 2020 | 2634 | 0.880 |
Why?
|
Genetic Predisposition to Disease | 13 | 2020 | 17446 | 0.760 |
Why?
|
Cell Cycle Proteins | 7 | 2023 | 3464 | 0.750 |
Why?
|
Founder Effect | 1 | 2021 | 189 | 0.740 |
Why?
|
DNA Mutational Analysis | 8 | 2018 | 4185 | 0.720 |
Why?
|
Embryo Implantation | 2 | 2018 | 272 | 0.700 |
Why?
|
Graves Disease | 2 | 2018 | 242 | 0.690 |
Why?
|
Phosphate-Binding Proteins | 1 | 2019 | 70 | 0.680 |
Why?
|
Eye Proteins | 5 | 2017 | 645 | 0.680 |
Why?
|
Cytoskeletal Proteins | 2 | 2019 | 1364 | 0.630 |
Why?
|
Birth Rate | 1 | 2018 | 170 | 0.610 |
Why?
|
Hedgehog Proteins | 1 | 2022 | 783 | 0.600 |
Why?
|
Genotype | 12 | 2022 | 12952 | 0.570 |
Why?
|
Kv1.5 Potassium Channel | 2 | 2023 | 5 | 0.560 |
Why?
|
Vesicular Transport Proteins | 1 | 2019 | 377 | 0.550 |
Why?
|
Embryo, Nonmammalian | 1 | 2019 | 895 | 0.540 |
Why?
|
RNA Splicing | 1 | 2020 | 908 | 0.530 |
Why?
|
Inheritance Patterns | 2 | 2020 | 340 | 0.520 |
Why?
|
Oocytes | 2 | 2018 | 1188 | 0.520 |
Why?
|
Mutation, Missense | 5 | 2020 | 2566 | 0.510 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 2 | 2018 | 322 | 0.490 |
Why?
|
TRPC Cation Channels | 1 | 2015 | 121 | 0.490 |
Why?
|
Receptor, Angiotensin, Type 1 | 1 | 2015 | 152 | 0.480 |
Why?
|
Endoplasmic Reticulum | 2 | 2021 | 1146 | 0.470 |
Why?
|
Retinal Degeneration | 2 | 2008 | 415 | 0.460 |
Why?
|
Microfilament Proteins | 2 | 2017 | 1152 | 0.450 |
Why?
|
ATP-Binding Cassette Transporters | 2 | 2007 | 560 | 0.450 |
Why?
|
Pedigree | 10 | 2021 | 4642 | 0.450 |
Why?
|
Proteins | 7 | 2023 | 6100 | 0.440 |
Why?
|
Telangiectasia, Hereditary Hemorrhagic | 1 | 2014 | 139 | 0.440 |
Why?
|
Fertilization in Vitro | 2 | 2018 | 1284 | 0.430 |
Why?
|
Endothelin-1 | 1 | 2014 | 314 | 0.420 |
Why?
|
Oligonucleotide Array Sequence Analysis | 6 | 2014 | 3921 | 0.420 |
Why?
|
Autophagy | 2 | 2021 | 1297 | 0.410 |
Why?
|
Embryonic Development | 1 | 2017 | 711 | 0.410 |
Why?
|
Alternative Splicing | 1 | 2017 | 1117 | 0.400 |
Why?
|
Polymorphism, Genetic | 6 | 2018 | 4328 | 0.400 |
Why?
|
Consanguinity | 4 | 2017 | 454 | 0.400 |
Why?
|
Genetic Loci | 2 | 2019 | 2575 | 0.400 |
Why?
|
Vitelliform Macular Dystrophy | 1 | 2011 | 12 | 0.400 |
Why?
|
Cilia | 4 | 2022 | 466 | 0.380 |
Why?
|
Phenotype | 10 | 2023 | 16367 | 0.380 |
Why?
|
Homozygote | 6 | 2021 | 1787 | 0.380 |
Why?
|
Hemodynamics | 3 | 2017 | 4196 | 0.370 |
Why?
|
Chloride Channels | 1 | 2011 | 227 | 0.360 |
Why?
|
Lymphocytes | 1 | 2017 | 2617 | 0.350 |
Why?
|
Lupus Erythematosus, Systemic | 2 | 2021 | 2104 | 0.340 |
Why?
|
Photoreceptor Cells, Vertebrate | 2 | 2010 | 204 | 0.340 |
Why?
|
Polymorphism, Single Nucleotide | 7 | 2020 | 15520 | 0.330 |
Why?
|
Lipids | 2 | 2021 | 3307 | 0.330 |
Why?
|
Promoter Regions, Genetic | 4 | 2015 | 5867 | 0.320 |
Why?
|
Alcohol Oxidoreductases | 1 | 2008 | 170 | 0.310 |
Why?
|
DNA Methylation | 3 | 2020 | 4285 | 0.310 |
Why?
|
Sequence Analysis, DNA | 6 | 2020 | 4805 | 0.270 |
Why?
|
Humans | 56 | 2023 | 744366 | 0.260 |
Why?
|
Female | 37 | 2021 | 380193 | 0.260 |
Why?
|
Male | 35 | 2021 | 350115 | 0.250 |
Why?
|
Case-Control Studies | 8 | 2018 | 21748 | 0.250 |
Why?
|
Middle Aged | 24 | 2021 | 213390 | 0.240 |
Why?
|
Protein Transport | 2 | 2022 | 1988 | 0.240 |
Why?
|
Genes, Recessive | 1 | 2006 | 641 | 0.230 |
Why?
|
High-Throughput Nucleotide Sequencing | 4 | 2020 | 3595 | 0.230 |
Why?
|
Heart Septal Defects | 1 | 2023 | 192 | 0.210 |
Why?
|
Adult | 20 | 2022 | 214052 | 0.210 |
Why?
|
Macular Degeneration | 2 | 2006 | 980 | 0.200 |
Why?
|
Alleles | 6 | 2017 | 6933 | 0.200 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2012 | 2917 | 0.200 |
Why?
|
T-Box Domain Proteins | 2 | 2022 | 471 | 0.200 |
Why?
|
HIV Infections | 3 | 2016 | 16715 | 0.190 |
Why?
|
Transcription Factors | 2 | 2017 | 12207 | 0.180 |
Why?
|
Phospholipid Transfer Proteins | 1 | 2021 | 91 | 0.180 |
Why?
|
DNA-Binding Proteins | 1 | 2017 | 9647 | 0.180 |
Why?
|
Lipid Metabolism | 3 | 2023 | 1889 | 0.180 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2023 | 11726 | 0.180 |
Why?
|
Cell Polarity | 1 | 2022 | 645 | 0.170 |
Why?
|
Genetic Variation | 4 | 2020 | 6542 | 0.160 |
Why?
|
Antithyroid Agents | 1 | 2018 | 70 | 0.160 |
Why?
|
Obesity | 1 | 2021 | 12746 | 0.160 |
Why?
|
Glaucoma, Open-Angle | 1 | 2005 | 706 | 0.160 |
Why?
|
Polymerase Chain Reaction | 4 | 2014 | 6171 | 0.160 |
Why?
|
Sterols | 1 | 2018 | 63 | 0.160 |
Why?
|
HIV-1 | 1 | 2015 | 6939 | 0.150 |
Why?
|
Scleroderma, Systemic | 1 | 2021 | 323 | 0.150 |
Why?
|
Oligonucleotides, Antisense | 1 | 2019 | 433 | 0.150 |
Why?
|
Microscopy, Polarization | 1 | 2017 | 88 | 0.150 |
Why?
|
Glycoproteins | 1 | 2005 | 2266 | 0.140 |
Why?
|
ADP-Ribosylation Factors | 1 | 2017 | 133 | 0.140 |
Why?
|
Cell Line, Transformed | 1 | 2017 | 898 | 0.140 |
Why?
|
Intracellular Space | 1 | 2017 | 212 | 0.140 |
Why?
|
Sperm Injections, Intracytoplasmic | 1 | 2017 | 160 | 0.140 |
Why?
|
Haplotypes | 2 | 2021 | 2779 | 0.140 |
Why?
|
5' Untranslated Regions | 1 | 2017 | 249 | 0.140 |
Why?
|
Extracellular Matrix | 1 | 2023 | 1741 | 0.130 |
Why?
|
Electrophoresis, Agar Gel | 1 | 2015 | 212 | 0.130 |
Why?
|
Transforming Growth Factor beta | 1 | 2023 | 2007 | 0.130 |
Why?
|
Genes, Reporter | 2 | 2017 | 1547 | 0.130 |
Why?
|
Chaperonins | 1 | 2015 | 62 | 0.130 |
Why?
|
Epigenomics | 1 | 2020 | 903 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2023 | 2504 | 0.130 |
Why?
|
Chorionic Gonadotropin | 1 | 2017 | 476 | 0.130 |
Why?
|
Base Sequence | 3 | 2017 | 12797 | 0.120 |
Why?
|
Retinitis Pigmentosa | 2 | 2010 | 386 | 0.120 |
Why?
|
Computational Biology | 2 | 2017 | 3519 | 0.120 |
Why?
|
Biological Transport | 1 | 2019 | 2120 | 0.120 |
Why?
|
Connective Tissue Diseases | 2 | 2020 | 264 | 0.120 |
Why?
|
Withholding Treatment | 1 | 2018 | 599 | 0.120 |
Why?
|
Heart Defects, Congenital | 3 | 2023 | 4583 | 0.120 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 2008 | 1572 | 0.120 |
Why?
|
Lung Transplantation | 1 | 2022 | 1155 | 0.120 |
Why?
|
Sweden | 1 | 2017 | 1341 | 0.120 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2023 | 2938 | 0.120 |
Why?
|
HEK293 Cells | 2 | 2023 | 4208 | 0.120 |
Why?
|
Algorithms | 1 | 2014 | 13882 | 0.120 |
Why?
|
Proteome | 1 | 2023 | 1798 | 0.120 |
Why?
|
Introns | 1 | 2016 | 992 | 0.120 |
Why?
|
Cohort Studies | 5 | 2020 | 40559 | 0.110 |
Why?
|
Herpesvirus 4, Human | 1 | 2017 | 1041 | 0.110 |
Why?
|
Lung Diseases | 1 | 2022 | 1887 | 0.110 |
Why?
|
Carrier Proteins | 3 | 2021 | 5023 | 0.110 |
Why?
|
Retinal Diseases | 1 | 2018 | 684 | 0.100 |
Why?
|
Pleural Effusion, Malignant | 1 | 2012 | 101 | 0.100 |
Why?
|
Electrooculography | 1 | 2011 | 118 | 0.100 |
Why?
|
CpG Islands | 1 | 2015 | 1170 | 0.100 |
Why?
|
Antitubercular Agents | 2 | 2010 | 1320 | 0.100 |
Why?
|
Cytochrome P-450 CYP2E1 | 1 | 2010 | 36 | 0.100 |
Why?
|
Genetic Heterogeneity | 1 | 2014 | 733 | 0.090 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 2017 | 1206 | 0.090 |
Why?
|
Proteomics | 1 | 2023 | 3638 | 0.090 |
Why?
|
Arylamine N-Acetyltransferase | 1 | 2010 | 86 | 0.090 |
Why?
|
Sampling Studies | 1 | 2011 | 623 | 0.090 |
Why?
|
Pulmonary Veno-Occlusive Disease | 2 | 2020 | 66 | 0.090 |
Why?
|
Fatal Outcome | 1 | 2014 | 1851 | 0.090 |
Why?
|
DNA Copy Number Variations | 1 | 2018 | 1941 | 0.090 |
Why?
|
Age of Onset | 1 | 2016 | 3270 | 0.090 |
Why?
|
Cell Cycle | 1 | 2017 | 2967 | 0.090 |
Why?
|
Denmark | 1 | 2011 | 738 | 0.080 |
Why?
|
Young Adult | 5 | 2020 | 56429 | 0.080 |
Why?
|
Prognosis | 6 | 2022 | 29060 | 0.080 |
Why?
|
Child | 8 | 2020 | 77709 | 0.080 |
Why?
|
Zebrafish | 1 | 2019 | 2996 | 0.080 |
Why?
|
Gene Expression Regulation | 2 | 2017 | 12073 | 0.080 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2017 | 1862 | 0.080 |
Why?
|
Blindness | 2 | 2010 | 615 | 0.080 |
Why?
|
Genes, Tumor Suppressor | 1 | 2012 | 1097 | 0.080 |
Why?
|
Gene Frequency | 2 | 2011 | 3587 | 0.080 |
Why?
|
Glioma | 1 | 2022 | 3401 | 0.080 |
Why?
|
Serotonin | 1 | 2011 | 1017 | 0.070 |
Why?
|
Kidney | 1 | 2023 | 7184 | 0.070 |
Why?
|
Binding Sites | 1 | 2015 | 6111 | 0.070 |
Why?
|
Glutathione Transferase | 1 | 2008 | 595 | 0.070 |
Why?
|
Molecular Sequence Data | 4 | 2013 | 18111 | 0.070 |
Why?
|
Escherichia coli Proteins | 1 | 2013 | 1050 | 0.070 |
Why?
|
Pregnancy | 2 | 2018 | 29144 | 0.070 |
Why?
|
DNA, Recombinant | 1 | 2006 | 476 | 0.070 |
Why?
|
Eye | 1 | 2010 | 729 | 0.070 |
Why?
|
Aged | 6 | 2017 | 163288 | 0.070 |
Why?
|
Receptors, Cell Surface | 1 | 2014 | 2865 | 0.060 |
Why?
|
Leucine | 1 | 2006 | 560 | 0.060 |
Why?
|
Pulmonary Artery | 2 | 2023 | 1912 | 0.060 |
Why?
|
Trabecular Meshwork | 1 | 2005 | 99 | 0.060 |
Why?
|
Consensus Sequence | 1 | 2005 | 378 | 0.060 |
Why?
|
Microsatellite Repeats | 1 | 2007 | 802 | 0.060 |
Why?
|
Heterozygote | 1 | 2011 | 2804 | 0.060 |
Why?
|
Frameshift Mutation | 1 | 2006 | 399 | 0.060 |
Why?
|
Membrane Proteins | 2 | 2021 | 7882 | 0.060 |
Why?
|
Nerve Tissue Proteins | 1 | 2017 | 4463 | 0.060 |
Why?
|
Gene Expression | 1 | 2017 | 7798 | 0.060 |
Why?
|
Genome, Human | 1 | 2017 | 4420 | 0.060 |
Why?
|
Antigens, CD | 1 | 2014 | 4026 | 0.060 |
Why?
|
SOXF Transcription Factors | 1 | 2023 | 29 | 0.060 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2020 | 705 | 0.060 |
Why?
|
Genetic Testing | 2 | 2020 | 3444 | 0.060 |
Why?
|
Neoplasm Proteins | 1 | 2015 | 3707 | 0.060 |
Why?
|
Arginine | 1 | 2006 | 944 | 0.050 |
Why?
|
Incidence | 1 | 2020 | 20952 | 0.050 |
Why?
|
Child, Preschool | 4 | 2020 | 41005 | 0.050 |
Why?
|
Visual Fields | 1 | 2008 | 1047 | 0.050 |
Why?
|
Chromosome Mapping | 1 | 2010 | 4740 | 0.050 |
Why?
|
Brain Neoplasms | 1 | 2022 | 8861 | 0.050 |
Why?
|
Membranes | 1 | 2021 | 173 | 0.050 |
Why?
|
Escherichia coli | 1 | 2013 | 4217 | 0.050 |
Why?
|
Disease Models, Animal | 1 | 2019 | 18034 | 0.050 |
Why?
|
Visual Acuity | 1 | 2008 | 2530 | 0.040 |
Why?
|
Lung Neoplasms | 2 | 2015 | 13104 | 0.040 |
Why?
|
Point Mutation | 1 | 2005 | 1624 | 0.040 |
Why?
|
Cell Line, Tumor | 1 | 2015 | 16690 | 0.040 |
Why?
|
Methimazole | 1 | 2018 | 41 | 0.040 |
Why?
|
Codon, Nonsense | 1 | 2020 | 281 | 0.040 |
Why?
|
Pulmonary Embolism | 1 | 2011 | 2375 | 0.040 |
Why?
|
Tomography, Optical Coherence | 1 | 2011 | 2657 | 0.040 |
Why?
|
Disease Progression | 1 | 2015 | 13286 | 0.040 |
Why?
|
Time Factors | 2 | 2018 | 40075 | 0.040 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2011 | 3047 | 0.040 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2022 | 871 | 0.040 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2015 | 5223 | 0.040 |
Why?
|
Graves Ophthalmopathy | 1 | 2018 | 117 | 0.040 |
Why?
|
Hyperthyroidism | 1 | 2018 | 295 | 0.030 |
Why?
|
Animals | 2 | 2019 | 168768 | 0.030 |
Why?
|
Adenocarcinoma | 1 | 2012 | 6364 | 0.030 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2022 | 1572 | 0.030 |
Why?
|
DNA Primers | 2 | 2010 | 2891 | 0.030 |
Why?
|
Siblings | 1 | 2018 | 854 | 0.030 |
Why?
|
Amino Acid Sequence | 3 | 2013 | 13814 | 0.030 |
Why?
|
Peptide Chain Termination, Translational | 1 | 2013 | 28 | 0.030 |
Why?
|
Severity of Illness Index | 1 | 2011 | 15535 | 0.030 |
Why?
|
Peptide Elongation Factors | 1 | 2013 | 62 | 0.030 |
Why?
|
Peptide Chain Elongation, Translational | 1 | 2013 | 33 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2018 | 1184 | 0.030 |
Why?
|
Protein Synthesis Inhibitors | 1 | 2013 | 192 | 0.030 |
Why?
|
Remission Induction | 1 | 2018 | 2385 | 0.030 |
Why?
|
ROC Curve | 1 | 2020 | 3528 | 0.030 |
Why?
|
Follow-Up Studies | 1 | 2014 | 39052 | 0.030 |
Why?
|
Genes, p16 | 1 | 2012 | 157 | 0.030 |
Why?
|
Gene Deletion | 1 | 2020 | 2751 | 0.030 |
Why?
|
Two-Hybrid System Techniques | 1 | 2013 | 464 | 0.030 |
Why?
|
DNA Modification Methylases | 1 | 2012 | 206 | 0.030 |
Why?
|
Receptors, Retinoic Acid | 1 | 2012 | 232 | 0.030 |
Why?
|
Consensus | 1 | 2020 | 2960 | 0.020 |
Why?
|
Models, Biological | 2 | 2021 | 9584 | 0.020 |
Why?
|
DNA Repair Enzymes | 1 | 2012 | 349 | 0.020 |
Why?
|
Amino Acid Motifs | 1 | 2013 | 937 | 0.020 |
Why?
|
Ribosomes | 1 | 2013 | 500 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2021 | 3589 | 0.020 |
Why?
|
Pyrazinamide | 1 | 2008 | 54 | 0.020 |
Why?
|
Sample Size | 1 | 2010 | 845 | 0.020 |
Why?
|
Aspartate Aminotransferases | 1 | 2008 | 418 | 0.020 |
Why?
|
Isoniazid | 1 | 2008 | 274 | 0.020 |
Why?
|
Rifampin | 1 | 2008 | 315 | 0.020 |
Why?
|
BRCA1 Protein | 1 | 2012 | 1149 | 0.020 |
Why?
|
Alanine Transaminase | 1 | 2008 | 592 | 0.020 |
Why?
|
Sequence Alignment | 1 | 2010 | 2256 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2020 | 12961 | 0.020 |
Why?
|
Adolescent | 3 | 2020 | 85779 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7282 | 0.010 |
Why?
|
Genes, Dominant | 1 | 2005 | 880 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2018 | 15078 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2018 | 13991 | 0.010 |
Why?
|
Tumor Suppressor Proteins | 1 | 2012 | 2850 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2012 | 6539 | 0.010 |
Why?
|
Peptides | 1 | 2013 | 4410 | 0.010 |
Why?
|
Survival Analysis | 1 | 2012 | 10252 | 0.010 |
Why?
|
Quality of Life | 1 | 2020 | 12802 | 0.010 |
Why?
|
Family | 1 | 2010 | 3147 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2008 | 6489 | 0.010 |
Why?
|
Prospective Studies | 2 | 2012 | 53290 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2018 | 63107 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2018 | 77460 | 0.010 |
Why?
|
Infant | 1 | 2010 | 35134 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2012 | 57776 | 0.000 |
Why?
|